Zenas BioPharma, Inc. (ZBIO) earnings: date, estimates and history
Price $28.01 · data as of November 13, 2026
Next earnings report
The date appears here once Zenas BioPharma confirms it, usually two to four weeks before the report.
Track record
Zenas BioPharma beat the consensus earnings estimate in 2 of its last 5 reports, by −37.4% on average. On report days the stock moved 2.3% on average, up or down.
Earnings history
| Reported | EPS estimate | EPS actual | Surprise | Revenue | Revenue growth | Stock move |
|---|---|---|---|---|---|---|
| November 5, 2026 Sep/2026 | $-1.27 | $-1.23 | +3.1% | $10M | — | −0.7% |
| August 13, 2026 Jun/2026 | $-0.76 | $-1.77 | −134.4% | $1M | — | −5.7% |
| May 13, 2026 Mar/2026 | $-1.54 | $-1.46 | +5.2% | — | — | −1.4% |
| March 16, 2026 Dec/2025 | $-1.19 | $-1.39 | −16.8% | — | — | −2.3% |
| November 12, 2025 Sep/2025 | $-0.85 | $-1.22 | −44.1% | — | — | +1.3% |
EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.
Frequently asked questions
When is Zenas BioPharma’s next earnings date?
Zenas BioPharma has not confirmed its next report date yet. Its last report was on November 5, 2026.
Did Zenas BioPharma beat earnings last quarter?
Yes, it reported EPS of $-1.23 on November 5, 2026 against an estimate of $-1.27 (a +3.1% surprise), and the stock moved −0.7% the next trading day.
What EPS do analysts expect next quarter?
The consensus estimate is $-1.31 per share on revenue of about $14M.
Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar